Endologix has patented a system for internal iliac preservation, allowing for precise deployment of a graft in vascular bifurcations. The method involves catheter placement, guidewire cannulation, and stent deployment for effective treatment. GlobalData’s report on Endologix gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Premium Insights Endologix LLC - Company Profile

Buy the Report

Premium Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on Endologix, Prosthetic cardiac valves was a key innovation area identified from patents. Endologix's grant share as of February 2024 was 59%. Grant share is based on the ratio of number of grants to total number of patents.

Endovascular system for internal iliac preservation

Source: United States Patent and Trademark Office (USPTO). Credit: Endologix LLC

A recently granted patent (Publication Number: US11918498B2) discloses a method for deploying a graft using a system that includes a catheter, guidewires, and outer sheaths. The method involves placing the catheter above a vasculature bifurcation, retracting the outer sheath to cannulate a branch of the bifurcation with a guidewire, and then expanding and deploying the stent or stent-graft using the outer sheath. The system may also include a slidable connector, stent securement component, and additional stent-grafts for deployment in the bifurcation branches.

Furthermore, the method includes steps such as advancing the catheter to reposition the guidewire, moving the delivery system towards the guidewire, and retracting the system from the vasculature. Additional components like a thread, slidable snare, and slidable sleeve are included in the system to facilitate the deployment process. The method aims to provide a precise and effective way of deploying grafts in vasculature bifurcations, ensuring proper positioning and securement of the stent or stent-graft within the branches. The patent highlights the importance of these techniques in improving outcomes for patients undergoing vascular interventions.

To know more about GlobalData’s detailed insights on Endologix, buy the report here.

Premium Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.